Free Initial Consultation
Toll Free:
defective drug attorneys st louis

St. Louis Pharmaceutical Blog

Thousands of Yaz Lawsuits Have Been Settled

As of August 11th, 2014, nearly 5,000 lawsuits involving the use of Yaz and Yasmin have yet to be settled. Bayer Pharmaceutical has doled out more than $1.8 billion in settlements with more suits to come.  The basis of these suits stem from the plaintiff assertions of improper notification of side effects, which include deep vein thrombosis, blood clots, heart attack, and stroke.
A recent study by the FDA has confirmed that Yaz, Yasmin, and all other variants increase the risk of incurring blood clots more so than other birth control pills and has ordered Bayer and other drug makers to disclose this information on the labeling.
These suits are sure to continue against Bayer as more are filed each day. If you or a loved one has used Yaz or Yasmin and experienced any of these side effects, please consult a medical health professional.

$100 Million NuvaRing Settlement Takes Effect

In recent drug litigation news, a $100 million settlement handed down by U.S. District Judge Rodney W. Sippel of St. Louis, MO last February has finally been able to take effect based on a 95% opt-in rate by participants of the suit against Merck & Co., the makers of the NuvaRing birth control product targeted in the suit. The settlement will be divided amongst the 3,800 claimants named in the suit. The claimants argued that NuvaRing was not tested properly and that the potential of harmful side effects were not openly shared with users of the product.
If you or a loved one has used NuvaRing and are experiencing unwanted to pain or anguish, contact a physician and then an attorney at The Roberts Law Firm.

Risperidone and Ropinirole Prescription Mix-Up

The drug Risperidone, which is more commonly referred to as Risperdal, has yet another mark against its record. However, this has nothing to do with the drug itself, but instead, pharmacists have been filling prescriptions intended for Ropinirole with Risperdal and vice versa.
To complicate matters even more, the drug Ropinirole is used to treat parkinson’s disease, while Risperdal is an antipsychotic prescribed to treat bipolar disorder, schizophrenia, and irritability for individuals diagnosed with autism, among other conditions.
This has created additional problems for those taking the drug Risperdal and added to the litany of complaints associated with it. The use of Risperdal has lead to side effects including, movement disorders, heart problems, diabetes, gynecomastia, and pituitary tumors that can be potentially deadly.
If you or a loved one has used Risperdal and experienced any of these side effects, please consult a medical health professional.

Lexapro Suicide Case May Proceed in Mississippi

A Lexapro suicide case may proceed in Mississippi even though a federal judge has dismissed claims of negligence brought against Forest Laboratories, Inc., the maker of the drug.
The Mississippi Product Liability Act limits product liability suits to a certain extent, and any appeal by the plaintiff will need to satisfy the parameters of that legislation.
Suicide is a possible side-effect of Lexapro. There is ongoing litigation related to many other Lexapro side-effects including birth defects, slowed growth rate, and weight changes.
If you have a case regarding Lexapro or if you would like more information, contact the Lexapro lawyers at The Roberts Law Firm by calling toll-free at 866-585-4570, or by filling out our simple online form.

Federal Jury Orders $9 Billion in Damages from Makers of Actos

A U.S. federal court in Lafayette, Louisiana recently ordered Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay a total of $9 billion in punitive damages due to side-effects of their diabetes drug Actos. The decision is being reported as the first of its kind in the U.S.
Actos, a drug developed to control blood sugar, was later found to carry risks of cancer for its users. The large sum ordered in damages—the seventh-largest to date in the country—was due to the federal jury’s decision that Takeda knowingly hid or downplayed facts regarding the drug’s risks. Some of the major plaintiffs in the case suffer from bladder cancer, which they say they have evidence was caused by using Actos.
While the $9 billion ordered by the jury will most likely be reduced later due to other legal stipulations about the sizes of such awards, the message sent to the pharmaceutical companies should be clear.

Testosterone Drugs Now Under Scrutiny

You may have seen it advertised quite a bit in the past year: prescription drugs aimed at treating low testosterone levels in men, or “low T,” as they call it. Recently, a study released by the University of North Texas has shown a possible correlation between an increased risk for brain damage among some men.
The study found an increased risk of brain damage—a very serious side-effect for any drug—in Caucasian men involved in the study, but not among Mexican-American men. In addition to this university study, the FDA has also been investigating possible side-effects related to testosterone therapy drugs. Several lawsuits have also been filed against the manufacturers of some of the drugs.
For more information on how the drug litigation attorneys at The Roberts Law Firm can help you if you have been affected by a serious side-effect of a prescription drug, please contact us.

Risperdal Use Linked to Diabetes

One troubling side effect of Risperdal is that it may increase the patient’s risk of diabetes. This risk is associated with another common side effect of Risperdal: weight gain. The combination of weight gain and Risperdal use can lead to a frightening mixture.
Among the litany of startling side effects, diabetes is especially troubling. The use of Risperdal perhaps accentuates the otherwise undiagnosed diabetic symptoms in the patient, but diagnosed or not, diabetes can be fatal.
Usually the most prevalent symptoms of diabetes are increased levels of thirst and frequent urination, unintended weight loss, constant fatigue, digestive issues, tingling sensation in the feet, slow healing cuts and bruises, and vision problems. If left undiagnosed, diabetes can lead to heart disease, nerve damage, stroke, and eventual blindness.
If you or a loved one are experiencing any of these symptoms, contact your family physician as soon as possible.

Risperdal Associated With Male Breast Development

Of the known physical side effects associated with Risperdal, there is one of which that is especially troubling for men.  The condition is known as gynecomastia and it relates to the growth of breasts by men who have taken the drug.  The development of male breasts can be exceptionally frustrating and cause a great deal of distress.
Multiple suits have been filed against Janssen Pharmaceuticals, Inc. and a recent study Dr. Mahyar Etminan from the The University of British Columbia concluded that men who had used Risperdal or a variant of the drug had a 69% elevated risk of developing gynecomastia.  Also, patients using Risperdal had a significantly greater risk of developing gynecomastia, as opposed to those who had used an alternate means of medication.  Dr. Etminan was quoted as saying there, “is a strong association between the use of Risperdal and gynecomastia.

Risperdal Side Effects From USA

Risperdal is a very dangerous prescription drug.  It was used to treat any manner of psychological disorders and has since been at the center of attention for many class action law suits.  The side effects that the drug induced is long and rather varied, but here is a shortened list.  For the complete listing please follow the link to the National Institutes of Health website.
If you have experienced any of these side effects as a result of Risperdal use, contact The Roberts Law Firm today for more information at 636-530-9199.

Pradaxa Lawsuits filed in federal court are consolidated into Multidistrict Litigation (MDL)

Pradaxa® lawsuits filed in federal court are consolidated into a Multidistrict Litigation (MDL) in the US District Court for the Southern District of Illinois. District Judge David Herndon is the Judge presiding over the MDL. As reported by The Madison-St. Clair Record on October 5, 2012 Judge Herndon set a schedule for four “bellwether” trials that would start in August 2014 and end in early 2015. Also reported by The Madison-St. Clair Record on January 10, 2013 Judge Herndon said attorney’s are well into the Discovery Phase with each side producing various documents “by the tens of thousands” and that they will begin to take depositions of people with Boehringer Ingelheim Pharmaceuticals.

Tags: , ,

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.